Policy & Advocacy

"While applied research appears to be in the ascendancy at the moment, it is important to remember that without an equal and ongoing commitment to basic science, there would soon be nothing to translate into applications."

FASEB expressed concern that without swift action, NIH will be left operating under a temporary budget that will significantly harm its ability to fund new research grants, initiate planned clinical trials, expand career opportunities for young investigators, and take advantage of critical new opportunities to advance biomedical research.

This plan will guide the research NICHD will support over the next five years, including studies in developmental biology, reproductive health, child development, pediatrics, population health, and medical rehabilitation.

"Scientific information is a commodity of high value, and its true potential can be harnessed only after compilation into these databases."

NIGMS invites GSA members to provide suggestions on additional technologies by September 30 that would be useful to biomedical researchers if incorporated into the institute’s programs.

A delay in completing FY 2025 spending bills means federal agencies will not be able to move forward on grant awards for FY 2025 and grant recipients may have to discontinue their activities or find other funding sources until they receive the FY 2025 funding.

The NIH is requesting recommendations from the research community on ways that we can improve the postdoctoral training experience and career progression in the biomedical field.

The resource is meant to assist the research community in understanding how NIH policies guide artificial intelligence (AI)-related research.

FASEB’s comments highlighted the need for more consistent data definitions and collection instruments to understand disability prevalence and impact on life and work in STEM research fields.

The US House and Senate Appropriations Committees will release their proposed funding bills for various federal agencies, including those overseeing biomedical research.

As House spending bills go through subcommittee markups, Senate appropriators laid out 302(b) allocations, despite lack of bi-partisan agreement, to speed up consideration for bills that will impact the NIH and NSF budgets.